Cargando…
Silica Nanoparticles as the Adjuvant for the Immunisation of Mice Using Hepatitis B Core Virus-Like Particles
Advances in nanotechnology and nanomaterials have facilitated the development of silicon dioxide, or Silica, particles as a promising immunological adjuvant for the generation of novel prophylactic and therapeutic vaccines. In the present study, we have compared the adjuvanting potential of commerci...
Autores principales: | Skrastina, Dace, Petrovskis, Ivars, Lieknina, Ilva, Bogans, Janis, Renhofa, Regina, Ose, Velta, Dishlers, Andris, Dekhtyar, Yuri, Pumpens, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4250084/ https://www.ncbi.nlm.nih.gov/pubmed/25436773 http://dx.doi.org/10.1371/journal.pone.0114006 |
Ejemplares similares
-
The Hepatitis B Virus Core Variants that Expose Foreign C-Terminal Insertions on the Outer Surface of Virus-Like Particles
por: Dishlers, Andris, et al.
Publicado: (2015) -
PreS1 Containing HBc VLPs for the Development of a Combined Therapeutic/Prophylactic Hepatitis B Vaccine
por: Dishlers, Andris, et al.
Publicado: (2023) -
A VLP Library of C-Terminally Truncated Hepatitis B Core Proteins: Correlation of RNA Encapsidation with a Th1/Th2 Switch in the Immune Responses of Mice
por: Sominskaya, Irina, et al.
Publicado: (2013) -
Preparation by alkaline treatment and detailed characterisation of empty hepatitis B virus core particles for vaccine and gene therapy applications
por: Strods, Arnis, et al.
Publicado: (2015) -
Production of the HBc Protein from Different HBV Genotypes in E. coli. Use of Reassociated HBc VLPs for Packaging of ss- and dsRNA
por: Petrovskis, Ivars, et al.
Publicado: (2021)